A
AuriGen Medical
Committed to delivering hope to the heart of our patients
About AuriGen Medical
We are proud to announce the successful first-in-human implantation of our innovative Zenith left atrial appendage occlusion (LAAO) device. The procedure, performed at Auckland City Hospital, is a crucial step in the clinical validation of our novel technology. “I am very encouraged by how the Zenith device performed in this important first case. The patient recovered exceptionally well” said Dr Matt O’Connor the implanting cardiologist. “The independent anchors of the Zenith device provide a distinct advantage by allowing easy repositioning and placement optimization of the implant without risking injury to the heart. This in combination with the intra-procedural leak analysis, represents a significant advance in the LAAO technology.”
Source: Dealroom company dataAt a glance
- Founded
- 2016
- Headquarters
- Galway, Ireland
- Sector
- Health Tech & Medtech
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed4 investors entered at this stage
- HIHorizon 2020 FTI (Fast Track to Innovation)
Enterprise Ireland
European Innovation Council
Western Development Commission
Series A1 investor entered at this stage
Spark Crowdfunding
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about AuriGen Medical on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See AuriGen Medical on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.